Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buffered Soluble Alendronate After Denosumab Discontinuation
NCT04403698Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alendronate in osteoporosis, sponsored by Ghent University Hospital. Started Nov 2019; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04403698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04403698.